High quality Hair Loss Solution CB-03-01 / Breezula / 17alpha - Propionate CAS No 19608-29-8 from China, China's leading Anti Hair Loss ... Sales & Support
5 but I refuse to take finasteride or minox and I refuse to wait another 3+ years before I do something about my recession. I will get every batch that I buy ...
It was nearly 22 years ago that the FDA approved Propecia (finasteride) to slow or stop the rate of hair loss and regrow hair. That was the last time the ...
08.04.2019 · Breezula (clascaterone) is said to possess powerful anti-androgen activity, some researchers suggest that Breezula (clascaterone) can inhibit androgens locally without eliminating the androgens systemically. This may sound very confusing, but allow me to explain why this piece of information is important. Genetic hair loss is triggered by the ...
17.04.2019 · Breezula Phase 3 trials have now been delayed till 4th quarter 2020 or 1st quarter 2021. All due to COVID-19 (Coronavirus), which has hit Italy particularly hard. More information can be found in Cassiopea’s 2019 Annual Results presentation, which was released today. The Clascoterone female pattern hair loss Phase 2 trials are on track to ...
13.10.2021 · The FDA recently approved the cream version for acne, though it is not yet available for sale. The brand names of clascoterone will be Winlevi for …
06.06.2021 · Breezula is said to inhibit Dyhdrotestoerone which can cause hair loss.This stops hair miniaturization, or thinning and loss - and as a result stops male / female pattern baldness. The thing that makes Breezula so special is that it will be the very first topical anti-androgen for hair loss in both men and women.
CB 03 01 is the code name for the hair loss treatment, also known as Clascoterone, that’s currently being developed and tested by Cassiopea. However, the chemical is available to purchase online as a research chemical, for use at the user’s own risk. The potential treatment is also referred to as ‘Breezula’.
07.12.2020 · Breezula is a new name-brand drug for clascoterone, a topical solution in development that may be used to treat androgenetic alopecia. While the clinical trials for Breezula seem promising so far, we’re still a while away from …